Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730918) titled 'Low-dose Propofol Plus High-dose Alfentanil in Rapid Sequence Induction' on July 23.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Aoyang Hospital Affiliated to Jiangsu University
Condition:
Hemodynamic Instability During Anesthesia
Induction Anesthesia
Intubation
Intervention:
Drug: propofol
Drug: alfentanil
Drug: Sufentanil
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 1, 2025
Target Sample Size: 172
Countries of Recruitment:...